During the past decade, Ospedale Civile di Faenza conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 7 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Civile di Faenza" #1 sponsor was "National Cancer Institute, Naples" with 7 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori" with 5 trials sponsored, "Sumitomo Pharma Oncology, Inc." with 3 trials sponsored and "Heart Care Foundation" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Civile di Faenza" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 3 trials as a collaborator, "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Civile di Faenza" are "Ovarian Cancer" (5 trials), "Breast Cancer" (2 trials), "Non-small Cell Lung Cancer Metastatic" (2 trials), "Non-small Cell Lung Cancer Stage IIIB" (2 trials) and "Advanced Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Ospedale Civile di Faenza" in a lesser frequency.

Most popular intervention types in "Ospedale Civile di Faenza" are "Drug" (27 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (5 trials), "Paclitaxel" (5 trials), "Bevacizumab" (4 trials), "Carboplatin" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Civile di Faenza" are 21 trials for "All" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Civile di Faenza". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Ospedale Civile di Faenza, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Civile di Faenza, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".